Ibuprofen/Diphenhydramine Hydrochloride

布洛芬/盐酸苯海拉明

Report date: 2026/05/24 20:00:34

Base Information

Drug NameIbuprofen/Diphenhydramine Hydrochloride
Drug Alias Name盐酸苯海拉明/布洛芬Diphenhydramine/Ibuprofen枸橼酸苯海拉明布洛芬Diphenhydramine Hydrochloride/IbuprofenDiphenhydramine Hydrochloride and Ibuprofen +[6] 
ClassificationSmall molecules
Mechanisms of ActionHistamine H1 receptor inverse agonistsCyclooxygenases inhibitors
TargetsHistamine H1 receptorCyclooxygenases
Therapy Area/IndicationsPainSleep Initiation and Maintenance Disorders
Global Approved IndicationsPainSleep Initiation and Maintenance Disorders
Approved Indications in ChinaPainSleep Initiation and Maintenance Disorders
Original Approved Country/TerritoryUnited States
Original Approved Date2005/12/21
Country/TerritoryUnited StatesMainland China
CombinationsYes IbuprofenDiphenhydramine Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesHaleon PLCChangchun Lanjiang Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsPainSleep Initiation and Maintenance Disorders
Inactive IndicationsN/A

Other Information

ATC CodeM01AE51R06AA52
Related LinksN/A